https://www.metastock.com/offer/event/?whc=traders-conference&pc=eq-leibovit
FREE – SIGN UP TODAY
WEEKLY PODCAST – NEXT PODCAST THURSDAY EVENING
https://www.howestreet.com/2025/04/silver-holding-up-as-gold-loosens-grip-mark-leibovit/
U.S. Stocks Move Mostly Higher On Optimism About Trade Deals
After showing a lack of direction early in the session, stocks moved mostly higher over the course of the trading day on Tuesday. With the upward move, the S&P 500 closed higher for the sixth straight session, reaching its best closing level in almost a month.
The major averages ended the day off their highs of the session but still firmly positive. The Dow jumped 300.03 points or 0.8 percent to 40,527.62, the S&P 500 climbed 32.08 points or 0.6 percent to 5,560.83 and the Nasdaq rose 95.18 points or 0.6 percent to 17,461.32.
The strength that emerged on Wall Street came amid positive developments on the trade front, with Commerce Secretary Howard Lutnick telling CNBC the Trump administration had reached its first trade deal.
Lutnick declined to name the country involved but said he expects their prime minister and parliament to give their approval “shortly.”
Treasury Secretary Scott Bessent also told reporters the U.S. is “very close” to a trade deal with India, has had “substantial talks” with Japan and has “the contours of a deal” with South Korea.
Earlier in the day, traders seemed reluctant to make significant moves ahead of the release of key earnings and economic news in the coming days.
Four of the “Magnificent Seven” companies – Amazon (AMZN), Apple (AAPL), Meta Platforms (META) and Microsoft (MSFT) – are among the companies due to report their quarterly results this week.
Big-name companies like Visa (V), Eli Lilly (LLY), Chevron (CVX) and Exxon Mobil (XOM) are also due to report their quarterly results.
The Labor Department’s monthly jobs report is also likely to be in focus later this week along with the Federal Reserve’s preferred readings on consumer price inflation.
Sector News
Pharmaceutical stocks showed a significant move to the upside on the day, driving the NYSE Arca Pharmaceutical Index up by 1.4 percent.
Drug giant Pfizer (PFE) helped lead the sector higher after reporting better than expected first quarter earnings and maintaining its full-year guidance.
Notable strength also emerged among telecom stocks, as reflected by the 1.1 percent gain posted by the NYSE Arca North American Telecom Index.
Software, networking and banking stocks also saw some strength on the day, while gold and semiconductor stocks moved to the downside.
Other Markets
In overseas trading, stock markets across the Asia-Pacific region turned in a mixed performance, with the Japanese markets closed for a holiday. China’s Shanghai Composite Index edged down by 0.1 percent, while Hong Kong’s Hang Seng Index crept up by 0.2 percent.
The major European markets also ended the day mixed. While the French CAC 40 Index dipped by 0.2 percent, the U.K.’s FTSE 100 Index rose by 0.6 percent and the German DAX Index climbed by 0.7 percent.
In the bond market, treasuries extended the upward trend seen over the past several sessions. As a result, the yield on the benchmark ten-year note, which moves opposite of its price, fell 4.3 basis points to 4.173 percent.
Looking Ahead
Trading on Tuesday may be impacted by reaction to a slew of U.S. economic data, including reports on private sector employment and first quarter GDP as well as the Federal Reserve’s preferred readings on consumer price inflation.
https://tinyurl.com/38ku54a5
ORDER NOW! Get 50% Off with promo code ‘HALFOFF’
A YEAR OLD BUT STILL A GOOD ARTICLE
https://slate.com/business/2024/02/cnbc-investing-advice-bad-making-money.html
BEST NEWS CHANNEL PERIOD! KEEP INFORMED ON THE ANTICS OF THE DEMOCRATS AND THEIR MISGUIDED POLICIES
https://www.youtube.com/@NewsmaxTV/featured
THE CASE FOR ABOLISHING THE FEDERAL RESERVE
https://www.youtube.com/@NewsmaxTV/featured
COME ON, DAD. IT’S TIME TO EAT
DISCLAIMER:
WE ARE NOT FINANCIAL ADVISORS AND DO NOT PROVIDE FINANCIAL ADVICE
The website, LeibovitVRNewsletters.com, is published by LeibovitVRNewsletters LLC.
In using LeibovitVRnewsletters.com (a/k/a LeibovitVRNewsletters LLC) you agree to these Terms & Conditions governing the use of the service. These Terms & Conditions are subject to change without notice. We are publishers and are not registered as a broker-dealer or investment adviser either with the U.S. Securities and Exchange Commission or with any state securities authority.
All stocks and ETFs discussed are HYPOTHETICAL and not actual trades whose actual execution may differ markedly from prices posted on the website and in emails. This may be due internet connectivity, quote delays, data entry errors and other market conditions. Hypothetical or simulated performance results have certain inherent limitations as to liquidity and execution among other variables. PAST RESULTS ARE NOT NECESSARILY INDICATIVE OF FUTURE FORECASTING ACCURACY OR PROFITABLE TRADING RESULTS.
All investments are subject to risk, which should be considered on an individual basis before making any investment decision. We are not responsible for errors and omissions. These publications are intended solely for information and educational purposes only and the content within is not to be construed, under any circumstances, as an offer to buy or to sell or a solicitation to buy or sell or trade in any commodities or securities named within.
All commentary is provided for educational purposes only. This material is based upon information we consider reliable. However, accuracy is not guaranteed. Subscribers should always do their own investigation before investing in any security. Furthermore, you cannot be assured that your will profit or that any losses can or will be limited. It is important to know that no guarantee of any kind is implied nor possible where projections of future conditions in the markets are attempted.
Stocks and ETFs may be held by principals of LeibovitVRNewsletters LLC whose personal investment decisions including entry and exit points may differ from guidelines posted.
LeibovitVRNewsletters.com cannot and do not assess, verify or guarantee the suitability or profitability of any particular investment. You bear responsibility for your own investment research and decisions and should seek the advice of a qualified securities professional before making any investment. As an express condition of using this service and anytime after ending the service, you agree not to hold LeibovitVRNewsletters.com or any employees liable for trading losses, lost profits or other damages resulting from your use of information on the Site in any form (Web-based, email-based, or downloadable software), and you agree to indemnify and hold LeibovitVRNewsletters.com and its employees harmless from and against any and all claims, losses, liabilities, costs, and expenses (including but not limited to attorneys’ fees) arising from your violation of this agreement. This paragraph is not intended to limit rights available to you or to us that may be available under the federal securities laws.
For rights, permissions, subscription and customer service, contact the publisher at mark.vrtrader@gmail.com or call at 928-282-1275 or mail to 10632 N. Scottsdale Road B-426, Scottsdale, AZ 85254.
The Leibovit Volume Reversal, Volume Reversal and Leibovit VR are registered trademarks.
© Copyright 2025. All rights reserved.
[/fusion_text][/fusion_builder_column][/fusion_builder_row][/fusion_builder_container]